Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALTO: Aliskiren/Ramipril/Amlodipine in Hypertension with Metabolic Syndrome
NCT00542269Phase 4Terminated
- Sponsor
- Novartis
- Start
- Mar 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aliskiren in hypertension (HTN), sponsored by Novartis. Started Mar 2008; status: terminated.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00542269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00542269.